Évaluation d’un test de dépistage du syndrome VEXAS à partir de l’entrepôt de données biomédicales du CHU de Bordeaux. Application en Rhumatologie
Year: 2023
Type: dissertation
Abstract: Introduction: VEXAS syndrome is an acquired monogenic auto-inflammatory disease linked to a mutation in the UBA1 gene discovered in 2020. This disease, which has a poor prognosis in the absence of treatment, combines systemic autoinflammatory disorders, particularly of the skin and joints, with dysmyelopoiesis. Early diagnosis using molecular biology is important, as certain therapies, such as bone marrow allografts, are curative. Main objective: to query the Bordeaux University Hospital Health Data Warehouse (HDW) via the i2b2 platform to detect VEXAS syndrome in at least one patient not tested for UBA1 mutation despite a compatible clinical history according to our eligibility criteria. Method: thirty thousand two hundred and ninety-seven files were selected from the HDW of the Bordeaux University Hospital via the i2b2 platform, enabling the extraction of files of interest by recognition of criteria previously defined from the literature. These 30,297 files were prioritized according to their number of criteria. The first 240 files were reviewed on the SmartCRF application to determine those actually eligible for UBA1 mutation testing, after elimination of differential diagnoses. Results: of the 240 files reviewed, 9 were those of VEXAS patients already diagnosed, and 49 were selected as eligible for UBA1 mutation testing. Only 15 patients could be tested on preserved genetic material, and 2 had a UBA1 mutation. Conclusion: the use of the i2b2 platform and SmartCRF to screen for VEXAS syndrome appears promising, but still has certain limitations.
Source: HAL
Author: Hamon, Alexis
Institution: Université de Bordeaux
Language: English
Topic: Genomics and Rare Diseases
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7047090027
